ID

24887

Descripción

A Study of MK0657 in Parkinson's Disease Patients (0657-006); ODM derived from: https://clinicaltrials.gov/show/NCT00505843

Link

https://clinicaltrials.gov/show/NCT00505843

Palabras clave

Versiones (1)
  1. 22/8/17 22/8/17 -
Subido en

22 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Parkinson's Disease NCT00505843

Inglés

Eligibility Parkinson's Disease NCT00505843

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
parkinson's disease patients between the ages of 40 and 80 inclusive
Descripción

Parkinson Disease | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030567
UMLS CUI [2]
C0001779
patient is in general good health based on screening assessments
Descripción

General health good

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1277245
patient is willing to discontinue anti-parkinson's medications at least 8 hours prior to dosing
Descripción

Antiparkinson Agents Discontinue Willing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003405
UMLS CUI [1,2]
C1444662
UMLS CUI [1,3]
C0600109
patient is levodopa responsive with levodopa-induced peak-dose dyskinesias
Descripción

Levodopa Responsive | Levodopa-induced dyskinesias Dose Peak

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023570
UMLS CUI [1,2]
C0205342
UMLS CUI [2,1]
C1970038
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0444505
patient taking selective serotonin inhibitors (ssris), sleep medications and neuroleptics, have been on a stable dose for at least 30 days and has not experienced any cns-related side effects
Descripción

Selective Serotonin Reuptake Inhibitors | taking medication to help sleep | Antipsychotic Agents | Pharmaceutical Preparations Dose Stable | Adverse effects CNS Related Absent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0360105
UMLS CUI [2]
C2054158
UMLS CUI [3]
C0040615
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
UMLS CUI [5,1]
C0879626
UMLS CUI [5,2]
C3714787
UMLS CUI [5,3]
C0439849
UMLS CUI [5,4]
C0332197
patient is not a heavy smoker or drinker
Descripción

Heavy smoker Absent | Alcoholic Intoxication Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0857118
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0001969
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient has atypical parkinson's syndrome due to drugs, identified metabolic and/or neurologic disorders, encephalitis, or other degenerative syndrome
Descripción

Atypical Parkinson Disease Due to Pharmaceutical Preparations | Atypical Parkinson Disease Due to Metabolic Diseases | Atypical Parkinson Disease Due to Nervous system disorder | Atypical Parkinson Disease Due to Encephalitis | Atypical Parkinson Disease Due to Degenerative disorder

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1868596
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0013227
UMLS CUI [2,1]
C1868596
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0025517
UMLS CUI [3,1]
C1868596
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0027765
UMLS CUI [4,1]
C1868596
UMLS CUI [4,2]
C0678226
UMLS CUI [4,3]
C0014038
UMLS CUI [5,1]
C1868596
UMLS CUI [5,2]
C0678226
UMLS CUI [5,3]
C1285162
patient has known intolerance or hypersensitivity to levodopa or carbidopa
Descripción

Intolerance to Levodopa | Levodopa allergy | Intolerance to Carbidopa | Hypersensitivity Carbidopa

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0023570
UMLS CUI [2]
C0570730
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C0006982
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0006982
patient has been on anticholinergics or memantine within 30 days prior to dosing
Descripción

Anticholinergic Agents | Memantine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242896
UMLS CUI [2]
C0025242
patients have a history of the following: seizure disorder, stroke or head trauma, pronounced cognitive impairment, psychiatric disorder, cardiovascular disease, cancer, diabetes as defined by hba1c of greater than 8%
Descripción

Epilepsy | Cerebrovascular accident | Craniocerebral Trauma | Impaired cognition Marked | Mental disorders | Cardiovascular Diseases | Malignant Neoplasms | Diabetes Mellitus | Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0014544
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0018674
UMLS CUI [4,1]
C0338656
UMLS CUI [4,2]
C1706089
UMLS CUI [5]
C0004936
UMLS CUI [6]
C0007222
UMLS CUI [7]
C0006826
UMLS CUI [8]
C0011849
UMLS CUI [9]
C0019018
patient has a systolic bp or less than 80 mm hg or greater than 150 mm hg
Descripción

Systolic Pressure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0871470
Volver a la parte superior de la página

Similar models

Eligibility Parkinson's Disease NCT00505843

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Parkinson Disease | Age
Item
parkinson's disease patients between the ages of 40 and 80 inclusive
boolean
C0030567 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
General health good
Item
patient is in general good health based on screening assessments
boolean
C1277245 (UMLS CUI [1])
Antiparkinson Agents Discontinue Willing
Item
patient is willing to discontinue anti-parkinson's medications at least 8 hours prior to dosing
boolean
C0003405 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0600109 (UMLS CUI [1,3])
Levodopa Responsive | Levodopa-induced dyskinesias Dose Peak
Item
patient is levodopa responsive with levodopa-induced peak-dose dyskinesias
boolean
C0023570 (UMLS CUI [1,1])
C0205342 (UMLS CUI [1,2])
C1970038 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0444505 (UMLS CUI [2,3])
Selective Serotonin Reuptake Inhibitors | taking medication to help sleep | Antipsychotic Agents | Pharmaceutical Preparations Dose Stable | Adverse effects CNS Related Absent
Item
patient taking selective serotonin inhibitors (ssris), sleep medications and neuroleptics, have been on a stable dose for at least 30 days and has not experienced any cns-related side effects
boolean
C0360105 (UMLS CUI [1])
C2054158 (UMLS CUI [2])
C0040615 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
C0879626 (UMLS CUI [5,1])
C3714787 (UMLS CUI [5,2])
C0439849 (UMLS CUI [5,3])
C0332197 (UMLS CUI [5,4])
Heavy smoker Absent | Alcoholic Intoxication Absent
Item
patient is not a heavy smoker or drinker
boolean
C0857118 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0001969 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Atypical Parkinson Disease Due to Pharmaceutical Preparations | Atypical Parkinson Disease Due to Metabolic Diseases | Atypical Parkinson Disease Due to Nervous system disorder | Atypical Parkinson Disease Due to Encephalitis | Atypical Parkinson Disease Due to Degenerative disorder
Item
patient has atypical parkinson's syndrome due to drugs, identified metabolic and/or neurologic disorders, encephalitis, or other degenerative syndrome
boolean
C1868596 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1868596 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0025517 (UMLS CUI [2,3])
C1868596 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0027765 (UMLS CUI [3,3])
C1868596 (UMLS CUI [4,1])
C0678226 (UMLS CUI [4,2])
C0014038 (UMLS CUI [4,3])
C1868596 (UMLS CUI [5,1])
C0678226 (UMLS CUI [5,2])
C1285162 (UMLS CUI [5,3])
Intolerance to Levodopa | Levodopa allergy | Intolerance to Carbidopa | Hypersensitivity Carbidopa
Item
patient has known intolerance or hypersensitivity to levodopa or carbidopa
boolean
C1744706 (UMLS CUI [1,1])
C0023570 (UMLS CUI [1,2])
C0570730 (UMLS CUI [2])
C1744706 (UMLS CUI [3,1])
C0006982 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0006982 (UMLS CUI [4,2])
Anticholinergic Agents | Memantine
Item
patient has been on anticholinergics or memantine within 30 days prior to dosing
boolean
C0242896 (UMLS CUI [1])
C0025242 (UMLS CUI [2])
Epilepsy | Cerebrovascular accident | Craniocerebral Trauma | Impaired cognition Marked | Mental disorders | Cardiovascular Diseases | Malignant Neoplasms | Diabetes Mellitus | Glycosylated hemoglobin A
Item
patients have a history of the following: seizure disorder, stroke or head trauma, pronounced cognitive impairment, psychiatric disorder, cardiovascular disease, cancer, diabetes as defined by hba1c of greater than 8%
boolean
C0014544 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0018674 (UMLS CUI [3])
C0338656 (UMLS CUI [4,1])
C1706089 (UMLS CUI [4,2])
C0004936 (UMLS CUI [5])
C0007222 (UMLS CUI [6])
C0006826 (UMLS CUI [7])
C0011849 (UMLS CUI [8])
C0019018 (UMLS CUI [9])
Systolic Pressure
Item
patient has a systolic bp or less than 80 mm hg or greater than 150 mm hg
boolean
C0871470 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial